Publications by authors named "Kirill Tsukanov"

Article Synopsis
  • The Open Targets Platform is an open-source knowledge base designed for identifying and prioritizing drug targets with enhanced data and tools.
  • Significant updates include a revamped target-disease associations page featuring interactive elements and a new Target Prioritisation view, allowing users to evaluate targets based on clinical relevance and safety.
  • The platform now also incorporates a direction of effect assessment from various evidence sources, illustrating how genetic variations impact target functions, thereby aiding in the understanding of disease treatment mechanisms.
View Article and Find Full Text PDF

Summary: Semantic ontology mapping of clinical descriptors with disease outcome is essential. ClinVar is a key resource for human variation with known clinical significance. We present CMAT, a software toolkit and curation protocol for accurately enriching ClinVar releases with disease ontology associations and complex functional consequences.

View Article and Find Full Text PDF
Article Synopsis
  • The Open Targets Platform is an open-source resource designed to help identify and prioritize drug targets using publicly available data.
  • The platform has undergone a complete redesign to improve data integration, user exploration, and overall user experience.
  • New features include enhanced gene-disease evidence, safety assessments for drug targets, and machine learning tools for extracting information from research literature.
View Article and Find Full Text PDF

Maximizing the personal, public, research, and clinical value of genomic information will require the reliable exchange of genetic variation data. We report here the Variation Representation Specification (VRS, pronounced "verse"), an extensible framework for the computable representation of variation that complements contemporary human-readable and flat file standards for genomic variation representation. VRS provides semantically precise representations of variation and leverages this design to enable federated identification of biomolecular variation with globally consistent and unique computed identifiers.

View Article and Find Full Text PDF
Article Synopsis
  • * A recent white paper, resulting from a strategic meeting of 11 ELIXIR Nodes in September 2018, outlines objectives to tackle CNV challenges like detection, interpretation, and data sharing.
  • * The paper suggests ways to align these tasks with ELIXIR's broader strategy and aims to integrate the new ELIXIR Community into the global conversation on genomic research.
View Article and Find Full Text PDF

Non-invasive prenatal testing (NIPT) for aneuploidy on Chromosomes 21 (T21), 18 (T18) and 13 (T13) is actively used in clinical practice around the world. One of the limitations of the wider implementation of this test is the high cost of the analysis itself, as high-throughput sequencing is still relatively expensive. At the same time, there is an increasing trend in the length of reads yielded by sequencers.

View Article and Find Full Text PDF

Background: Liddle syndrome is a monogenic disease with autosomal dominant inheritance. Basic characteristics of this disease are hypertension, reduced concentration of aldosterone and renin activity, as well as increased excretion of potassium leading to low level of potassium in serum and metabolic alkalosis. The cause of Liddle syndrome is missense or frameshift mutations in SCNN1A, SCNN1B, or SCNN1G genes that encode epithelial sodium channel subunits.

View Article and Find Full Text PDF

We report a Russian patient with atypical onset of infantile nephropathic cystinosis. The disease debuted with vomiting and loss of weight and motor skills. Nephropathic changes appeared 6 months after onset of disease.

View Article and Find Full Text PDF

Background: Neuronal ceroid lipofuscinoses (NCLs) are the most common autosomal recessive neurodegenerative disorders in children. Clinical manifestations include progressive cognitive decline, motor impairment, ataxia, visual loss, seizures and early death. To date more than 440 NCL-causing mutations in 13 genes are known.

View Article and Find Full Text PDF